IM injection achieves faster initial uptake but produces a shorter duration of action
Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort
Further clarification is needed on the appropriate supplemental dose and corresponding time points
The mucosa-associated lymphoid tissue lymphoma translocator protein 1 (MALT1) protease has been shown to play an irreplaceable role in the regulation of GLS1 expression in B-cell lymphomas (78)
Summers first book, Living Your Healthiest Semaglutide Life, will be published in July 2025
Follow your doctors recommendations